Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
2.600
+0.430 (19.82%)
Feb 21, 2025, 4:00 PM EST - Market closed
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $260.85 million as of February 21, 2025. Its market cap has decreased by -67.08% in one year.
Market Cap
260.85M
Enterprise Value
-294.14M
1-Year Change
-67.08%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $260.85M, a decrease of -84.37%. That is a compound annual growth rate of -64.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 217.71M | -30.89% |
| Dec 31, 2024 | 315.02M | -56.62% |
| Dec 29, 2023 | 726.15M | -56.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |